271) Patient-Centered Education and Facilitativ |
272) idance, Facilitative Decision-Making, and Patient-Centered Education. |
273) The patient achieved HBsAg seroconversion with |
274) Long-term mECT was administered and the patient achieved remission with no notable |
275) linicopathological features studied, mean patient age was significantly higher in at |
276) 95% CI 0·996-0·999; P = 0·005) and patient's age (HR 1·009, 95% CI 1·001-1 |
277) sts and personal living conditions of the patient as well as the expertise and exper |
278) Care of critically ill patients, as in any other field, demands t |
279) methods can include direct observation of patient assessment and treatment skills, s |
280) orporation of tablet computers (TCs) into patient assessment may facilitate safe and |
281) Postoperative course was favorable, the patient being discharged on the seventh po |
282) is is the longest reported follow-up of a patient being off steroids while on MMF. |
283) Management of the advanced heart failure patient can be complex. |
284) timal perioperative management of the old patient can improve the results of surgica |
285) Patient-specific computational fluid dynam |
286) y, we propose a semi-automated method for patient-specific computational flow modell |
287) Critically, it requires patient data and additional auditing of pr |
288) In this analysis, patient-level data from 31 randomized clin |
289) 10, with an incidence rate of 4.09/10 000 patient days in 2009 and 5.9/10 000 patien |
290) 2010 were analyzed and benchmarked using patient days. |
291) ound differences in their perspectives on patient empowerment and attributions of co |
292) gest novel research approaches to improve patient empowerment and medical engagement |
293) d four broad subtypes of URVs: related to patient factors, to the illness, to the sy |
294) This paper investigates whether patient-level factors, in particular cost |
295) anti-inflammatory drugs prescribed to one patient for a short period. |
296) trained and a navigator assigned to each patient for at least 2 months. |
297) The results demonstrate that rapid patient-side immunomigration assays design |
298) ections induced by BRSV by means of rapid patient-side immunomigration assays used f |
299) detailed understanding of the individual patient including their developmental stat |
300) important in the care of a critically ill patient, including the common errors to av |
301) ile educational interventions to increase patient motivation to pursue living donor |
302) nt determinants of effectiveness, such as patient's motivation and goal-directed reh |
303) A patient of 42 years is followed in Physica |
|